Grand River Hospital

Kitchener, Ontario N2H 5Z8

1 studies enrolling now · 12 studies all time

What they study most

Anastomotic Leak, Antibiotic-associated Diarrhea, Breast Cancer, C-Difficile, COVID-19, Community-acquired Pneumonia, Influenza, COVID-19, Critical Illness, Deep Venous Thrombosis, Diarrhea, Fistula, Gastrointestinal Hemorrhage (Clinically Important, Upper), HER2+ Metastatic Breast Cancer (MBC)

Studies at this site

• Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia — Recruiting now
• Use of NERv's Inline Device as an Early Diagnostic Method for Postoperative Complications — Completed
• Re-EValuating the Inhibition of Stress Erosions (REVISE) Trial — Completed
• A Study of Atezolizumab and Paclitaxel Versus Placebo and Paclitaxel in Participants With Previously Untreated Locally Advanced or Metastatic Triple Negative Breast Cancer (TNBC) — Completed
• HIP Fracture Accelerated Surgical TreaTment And Care tracK (HIP ATTACK) Trial — Completed
• A Study of Taselisib + Fulvestrant Versus Placebo + Fulvestrant in Participants With Advanced or Metastatic Breast Cancer Who Have Disease Recurrence or Progression During or After Aromatase Inhibitor Therapy — Stopped early
• CONvalescent Plasma for Hospitalized Adults With COVID-19 Respiratory Illness (CONCOR-1) — Stopped early
• A Study of Neratinib Plus Capecitabine Versus Lapatinib Plus Capecitabine in Patients With HER2+ Metastatic Breast Cancer Who Have Received Two or More Prior HER2 Directed Regimens in the Metastatic Setting — Completed
• Probiotics to Prevent Severe Pneumonia and Endotracheal Colonization Trial — Completed
• A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa — Completed
• Expanded Access Program With Nivolumab in Combination With Ipilimumab in Patients With Tumors Unable to be Removed by Surgery or Metastatic Melanoma — NO_LONGER_AVAILABLE
• PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT) — Completed